DCPH

Deciphera Pharmaceuticals Inc.

Price

return (12m)

p/e

-11.70

p/bv

7.05

DIVIDEND YIELD

0.00%

DCPH price

Deciphera Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment DCPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals DCPH

Valuation

P/E

-11.70

Sector -3.50

Industry -3.50

P/BV

7.05

Sector 2.02

Industry 2.02

P/Revenue (PSR)

12.74

Sector 2.01

Industry 2.01

EV/EBITDA

-46.03

Sector -214.99

Industry -214.99

EV/EBIT

-45.61

Sector -47.59

Industry -47.59

P/EBITDA

-10.79

Sector -21.41

Industry -21.41

P/EBIT

-10.69

Sector -28.65

Industry -28.65

P/Total Assets

5.29

Sector 1.19

Industry 1.19

P/Net Current Assets

9.09

Sector -11.97

Industry -11.97

P/Working Capital

8.36

Sector -167.95

Industry -167.95

EPS

-2.19

Sector -1.81

Industry -1.81

BVPS

3.63

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

96.95%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-107.56%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-108.56%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.11

Sector 0.02

Industry 0.02

Profitability

ROE

-60.25%

Sector -56.04%

Industry -56.04%

ROA

-45.24%

Sector -60.31%

Industry -60.31%

ROIC

-170.81%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.19

Sector 2.89

Industry 2.89

Net Debt / EBITDA

0.00

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

0.00

Sector -8.06

Industry -8.06

Net Debt / Equity

0.00

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.75

Sector 0.46

Industry 0.46

Liabilities/Assets

0.75

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

12.71%

Sector -

Industry -

5Y Earnings CAGR

-8.69%

Sector -

Industry -

Fundamentals DCPH

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
DCPH Deciphera Pharmaceuticals Inc.	$0.00	-	0.00%	-11.70	7.05	-60.25%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

DCPH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Deciphera Pharmaceuticals

Deciphera Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

9 years

Founded: 2017

2017

Time since IPO - 9 years

350

Employees

Deciphera Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.23 billion, with shareholders equity totaling $316.05 million.

The company employs approximately 350 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Deciphera Pharmaceuticals Inc. reported $174.91 million in revenue, generating net income of $-190.41 million.

Key financial metrics include a P/E ratio of -11.70, a price-to-book (P/B) ratio of 7.05, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DCPH.

Market cap

$2.23 billion

Net worth

$316.05 million

$316,050,000.00

Assets

$420.93 million

$420,930,000.00

Total Shares Outstanding

87.00 million

87,000,000

Average Daily Trading Volume

$2.14 million

$2,143,751.60

Sector

Health Care

Industry

Biotechnology

DCPH

DCPH revenue and profits

Financial Results DCPH

DRAG THE FRAME TO SEE MORE DATA

DCPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Deciphera Pharmaceuticals (DCPH) today?

A cotação de Deciphera Pharmaceuticals (DCPH) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Deciphera Pharmaceuticals (DCPH) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Deciphera Pharmaceuticals (DCPH) e dados de ações do Ibovespa e mercados internacionais.

Quando Deciphera Pharmaceuticals (DCPH) paga dividendos?

Deciphera Pharmaceuticals (DCPH) não distribuiu dividendos no último ano.

Is Deciphera Pharmaceuticals (DCPH) a good investment?

Atualmente, Deciphera Pharmaceuticals (DCPH) está cotada a US$ 0.00, com um P/L de -11.70, representando um desvio de -843% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Deciphera Pharmaceuticals (DCPH) stock?

Investir em ações de Deciphera Pharmaceuticals (DCPH) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Deciphera Pharmaceuticals (DCPH) yield today?

A rentabilidade de Deciphera Pharmaceuticals (DCPH) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Deciphera Pharmaceuticals (DCPH) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

DCPH

Deciphera Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment DCPH

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING DCPH WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Deciphera Pharmaceuticals

Deciphera Pharmaceuticals Inc.

United States

9 years

2017

350

PROFIT X PRICE DCPH

Financial Results DCPH

DCPH cash flow

Asset, Revenue and Profit Growth - DCPH

DCPH balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions